Daniel Newman Mendelson is Director at CHAMPIONS ONCOLOGY, INC. (CSBR). They have made 30 open-market trades across 1 company since 2014, most recently 2024-01-12.
CIK 0001327897
28 open-market purchases totalling $557K since 2014, against 2 sales. Across 28 scored buys the stock is down 5.1% at ninety days, and 15.2 points behind the S&P over the same stretch.
28 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 61% | 36% | 32% |
| Avg Move | +4.7% | +0.8% | -5.1% |
| Alpha | +4.7% | -2.1% | -15.2% |
| Scored | 28 | 28 | 28 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CSBR | BUY | 2024-01-12 | 2024-01-16 | $6.50 | $7K | -9.3% | -17.8% | -27.5% |
| CSBR | BUY | 2024-01-11 | 2024-01-12 | $6.27 | $13K | -12.9% | -14.1% | -29.7% |
| CSBR | BUY | 2024-01-10 | 2024-01-11 | $6.31 | $19K | -6.0% | -7.4% | -23.9% |
| CSBR | BUY | 2024-01-09 | 2024-01-10 | $6.25 | $19K | -0.5% | -0.8% | -19.0% |
| CSBR | BUY | 2024-01-08 | 2024-01-09 | $6.15 | $6K | -1.7% | -6.9% | -23.3% |
| CSBR | BUY | 2024-01-05 | 2024-01-08 | $6.09 | $12K | +6.7% | -2.8% | -20.3% |
| CSBR | BUY | 2024-01-04 | 2024-01-08 | $6.12 | $18K | +6.7% | -2.8% | -20.3% |
| CSBR | BUY | 2024-01-03 | 2024-01-04 | $5.83 | $3K | +13.2% | -0.5% | -17.8% |
| CSBR | BUY | 2023-12-21 | 2023-12-26 | $4.92 | $12K | +17.8% | +17.0% | -0.2% |
| CSBR | BUY | 2023-12-20 | 2023-12-21 | $4.82 | $10K | +22.7% | +28.4% | +10.7% |
| CSBR | BUY | 2023-12-19 | 2023-12-20 | $4.75 | $24K | +27.1% | +37.8% | +5.4% |
| CSBR | BUY | 2023-10-11 | 2023-10-13 | $6.40 | $32K | +1.6% | -14.8% | -3.3% |
| CSBR | BUY | 2023-10-10 | 2023-10-11 | $6.41 | $7K | +6.5% | -7.3% | +3.7% |
| CSBR | BUY | 2023-10-06 | 2023-10-10 | $6.48 | $10K | +0.5% | -14.3% | -4.1% |
| CSBR | BUY | 2023-10-05 | 2023-10-06 | $6.47 | $13K | -2.2% | -12.3% | -6.2% |
| CSBR | BUY | 2023-10-04 | 2023-10-04 | $6.40 | $32K | -2.0% | -14.4% | -10.1% |
| CSBR | BUY | 2023-10-03 | 2023-10-04 | $6.30 | $16K | -2.0% | -14.4% | -10.1% |
| CSBR | BUY | 2023-09-29 | 2023-10-16 | $6.16 | $25K | -4.4% | -13.1% | +6.8% |
| CSBR | BUY | 2023-09-28 | 2023-10-16 | $6.22 | $31K | -4.4% | -13.1% | +6.8% |
| CSBR | BUY | 2023-09-27 | 2023-10-16 | $5.95 | $9K | -4.4% | -13.1% | +6.8% |
| CSBR | BUY | 2023-09-26 | 2023-09-27 | $5.65 | $28K | +7.4% | -5.0% | -17.2% |
| CSBR | BUY | 2023-09-22 | 2023-09-25 | $5.50 | $21K | +12.9% | +18.8% | -8.7% |
| CSBR | BUY | 2023-09-21 | 2023-09-25 | $5.51 | $28K | +12.9% | +18.8% | -8.7% |
| CSBR | BUY | 2023-09-20 | 2023-09-25 | $5.51 | $22K | +12.9% | +18.8% | -8.7% |
| CSBR | BUY | 2023-09-19 | 2023-09-25 | $5.28 | $26K | +12.9% | +18.8% | -8.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.